Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

PSQ Capital

Investor type Family Investment Office

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$46M
Portfolio companies 1
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Therapeutics

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of PSQ Capital:
Typical Co-investors
PSQ Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after PSQ Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accton Technology Hsinchu, Taiwan, Taiwan Province
Anicom Capital Chiyoda, Japan
Aurum Investments Central, Central Region, Singapore
Combi Group Japan, Tokyo
Cornell University Ithaca, New York, United States
Crealize Essen, Germany, Nordrhein-Westfalen
DK Gate Japan, Tokyo
Five Corners Capital British Columbia, Canada, White Rock
Five Mill Ventures California, San Francisco, United States
Gakken -
INE Ventures Pennsylvania, Philadelphia, United States
Phoenix Holdings -
Rancho Santa Fe Partners California, Santa Fe Springs, United States
Shaoxing Junhe Touzi Youxian Gongsi China, Shaoxing, Zhejiang
Unovis Asset Management New York, New York, United States
Weber Capital California, San Francisco, United States
Zone 5 Ventures California, Morgan Hill, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ONL Therapeutics

Biotechnology
Pharmaceutical
Therapeutics
$46M22 Dec 2020 Ann Arbor, Michigan, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent PSQ Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: